162 related articles for article (PubMed ID: 16465038)
21. Growth of new bone guided by implants in a murine calvarial model.
Freilich M; M Patel C; Wei M; Shafer D; Schleier P; Hortschansky P; Kompali R; Kuhn L
Bone; 2008 Oct; 43(4):781-8. PubMed ID: 18589010
[TBL] [Abstract][Full Text] [Related]
22. Regenerating the periodontium: is there a magic formula?
Foster BL; Somerman MJ
Orthod Craniofac Res; 2005 Nov; 8(4):285-91. PubMed ID: 16238609
[TBL] [Abstract][Full Text] [Related]
23. [Effect of bone morphogenetic protein: experimental study of the implants-bone interface integration].
Zhou JC
Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):139-41, 189. PubMed ID: 8391907
[TBL] [Abstract][Full Text] [Related]
24. Regenerative potential and healing dynamics of the periodontium: a critical-size supra-alveolar periodontal defect study.
Polimeni G; Susin C; Wikesjö UM
J Clin Periodontol; 2009 Mar; 36(3):258-64. PubMed ID: 19236538
[TBL] [Abstract][Full Text] [Related]
25. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process.
Issa JP; Bentley MV; Iyomasa MM; Sebald W; De Albuquerque RF
Anat Histol Embryol; 2008 Jun; 37(3):181-7. PubMed ID: 18070240
[TBL] [Abstract][Full Text] [Related]
26. Delivery systems for bone morphogenetic proteins. A summary of experimental studies in primate models.
Ripamonti U
Ann Chir Gynaecol Suppl; 1993; 207():13-24. PubMed ID: 8154827
[TBL] [Abstract][Full Text] [Related]
27. Induction of cementogenesis and periodontal ligament regeneration by recombinant human transforming growth factor-beta3 in Matrigel with rectus abdominis responding cells.
Ripamonti U; Parak R; Petit JC
J Periodontal Res; 2009 Feb; 44(1):81-7. PubMed ID: 18973524
[TBL] [Abstract][Full Text] [Related]
28. The effects of recombinant human growth/differentiation factor-5 (rhGDF-5) on bone regeneration around titanium dental implants in barrier membrane-protected defects: a pilot study in the mandible of beagle dogs.
Weng D; Poehling S; Pippig S; Bell M; Richter EJ; Zuhr O; Hürzeler MB
Int J Oral Maxillofac Implants; 2009; 24(1):31-7. PubMed ID: 19344022
[TBL] [Abstract][Full Text] [Related]
29. Combination of scaffold and adenovirus vectors expressing bone morphogenetic protein-7 for alveolar bone regeneration at dental implant defects.
Zhang Y; Song J; Shi B; Wang Y; Chen X; Huang C; Yang X; Xu D; Cheng X; Chen X
Biomaterials; 2007 Nov; 28(31):4635-42. PubMed ID: 17664001
[TBL] [Abstract][Full Text] [Related]
30. Use of bone morphogenetic proteins for augmentation of bone regeneration.
Kirker-Head CA; Boudrieau RJ; Kraus KH
J Am Vet Med Assoc; 2007 Oct; 231(7):1039-55. PubMed ID: 17916029
[TBL] [Abstract][Full Text] [Related]
31. The application of an enamel matrix protein derivative (Emdogain) in regenerative periodontal therapy: a review.
Sculean A; Schwarz F; Becker J; Brecx M
Med Princ Pract; 2007; 16(3):167-80. PubMed ID: 17409750
[TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic proteins in clinical applications.
Gautschi OP; Frey SP; Zellweger R
ANZ J Surg; 2007 Aug; 77(8):626-31. PubMed ID: 17635273
[TBL] [Abstract][Full Text] [Related]
33. Discovery and development of BMPs.
Dimitriou R; Giannoudis PV
Injury; 2005 Nov; 36 Suppl 3():S28-33. PubMed ID: 16188546
[TBL] [Abstract][Full Text] [Related]
34. Bone morphogenetic proteins and the induction of periodontal tissue regeneration.
Ripamonti U; Renton L
Periodontol 2000; 2006; 41():73-87. PubMed ID: 16686927
[No Abstract] [Full Text] [Related]
35. Lateral ridge augmentation using particulated or block bone substitutes biocoated with rhGDF-5 and rhBMP-2: an immunohistochemical study in dogs.
Schwarz F; Rothamel D; Herten M; Ferrari D; Sager M; Becker J
Clin Oral Implants Res; 2008 Jul; 19(7):642-52. PubMed ID: 18492078
[TBL] [Abstract][Full Text] [Related]
36. Vertical ridge augmentation using guided bone regeneration (GBR) in three clinical scenarios prior to implant placement: a retrospective study of 35 patients 12 to 72 months after loading.
Urban IA; Jovanovic SA; Lozada JL
Int J Oral Maxillofac Implants; 2009; 24(3):502-10. PubMed ID: 19587874
[TBL] [Abstract][Full Text] [Related]
37. Recent outcomes and perspectives of the application of bone morphogenetic proteins in implant dentistry.
Salata LA; Franke-Stenport V; Rasmusson L
Clin Implant Dent Relat Res; 2002; 4(1):27-32. PubMed ID: 11938635
[TBL] [Abstract][Full Text] [Related]
38. Marginal bone stability using 3 different flap approaches for alveolar split expansion for dental implants: a 1-year clinical study.
Jensen OT; Cullum DR; Baer D
J Oral Maxillofac Surg; 2009 Sep; 67(9):1921-30. PubMed ID: 19686930
[TBL] [Abstract][Full Text] [Related]
39. Clinical and histologic evaluation of allogeneic bone matrix versus autogenous bone chips associated with titanium-reinforced e-PTFE membrane for vertical ridge augmentation: a prospective pilot study.
Fontana F; Santoro F; Maiorana C; Iezzi G; Piattelli A; Simion M
Int J Oral Maxillofac Implants; 2008; 23(6):1003-12. PubMed ID: 19216268
[TBL] [Abstract][Full Text] [Related]
40. Bone morphogenetic proteins: a powerful osteoinductive compound with non-negligible side effects and limitations.
Oryan A; Alidadi S; Moshiri A; Bigham-Sadegh A
Biofactors; 2014; 40(5):459-81. PubMed ID: 25283434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
